Leadership
Vice President Selection Panel
-
Dr Marco Huesch
Ping An Global Voyager Fund
(China)
Senior Advisor
Selection Panel Members
All companies joining the Tech Tour Health 2021 programme have been selected by the Selection Panel. This Selection Panel is responsible for nominating companies and will select the best 40 companies to take part in the programme.
Susana Amorim
Investment Manager
Gilde Healthcare Partners
(Netherlands)
Roberto Ascione
CEO
Healthware Group
(Italy)
Aynur Aydeldinov
CEO
Investment and Venture Fund of the Republic of Tatarstan
(Russian Federation)
Frank Bulens
Partner
imec.xpand
(Belgium)
Lien Callens
Investment Principal
imec.xpand
(Belgium)
Barbara Castellano
Investor
Panakès Partners
(Italy)
Evan Castiglia
Investment Partner
Philips
(Netherlands)
Pierre Chauvineau
Sequana Medical
(Switzerland)
Thijs Cohen Tervaert
Director
INKEF Capital
(Netherlands)
Raphael Conz
Managing Director
State of Vaud, Office for Economic Affairs and Innovation (SPEI)
(Switzerland)
Alain Coudray
President of the Healthtech Summit 2019
Healthtech Summit 2019
(Switzerland)
Antoine D'Hollander
Investment Manager
Capricorn Partners
(Belgium)
Marc Dietrich
Investment Manager
MTIP
(Switzerland)
Robert Garber
Partner
7wireVentures
(United States)
David Germonpré
Partner
MTIP
(Switzerland)
Julien Guex
Secretary
Foundation for Innovative Technology (FIT)
(Switzerland)
Vishal Gulati
Investor
Molten Ventures
(United Kingdom)
Claas Heise
Executive Director
NRW Bank
(Germany)
Dr Marco Huesch
Senior Advisor
Ping An Global Voyager Fund
(China)
Valery Huot
Partner, Head of Venture
LBO France
(France)
Matthew J Meyer
Chief Client Corporate Development Advisor
Wilson Sonsini Goodrich & Rosati
(United States)
Erik Janssen
Vice President Global Digital Transformation at UCB Pharma
UCB
(Belgium)
Dieter Kraft
Managing Director
TRUMPF Venture
(Germany)
Petri Laine
Managing Partner
Innovestor Ventures
(Finland)
Rana Lonnen
Managing Director, dRx Capital
Novartis
(Switzerland)
Julien Michaux
Head of Venture Investments
Norgine Ventures
(United Kingdom)
Marco Mohwinckel
Chief Commercial Officer
COMPASS Pathways & HealthTech
(United Kingdom)
Natalia Mühlemann
Vice President, Strategic Consulting
Cytel
(Switzerland)
Shinichi Nikkuni
Managing Partner
NordicNinjaVC
(Finland)
Cedric Odje
Investment Associate
Debiopharm Innovation Fund
(Switzerland)
Fernando Pacheco
Investment Manager
Endeavour Vision S.A.
(Switzerland)
Xavier Pardo
International Medical Device Executive
-
(Switzerland)
Sophie Park
Chief Strategist, Bayer G4A Partnerships
Bayer G4A
(Germany)
Luke Parsons
Vice President
Summit Partners
(United States)
Martin Piehlmeier
Vice President
Bryan, Garnier & Co
(Germany)
Thom Rasche
Partner
Earlybird Venture Capital
(Germany)
Hervé Ronin
Partner, Healthcare
Bryan, Garnier & Co
(Germany)
Christoph Ruedig
Partner
Albion Capital
(United Kingdom)
Emilien Schenker
Grants & Program Manager
State of Vaud, Office for Economic Affairs and Innovation (SPEI)
(Switzerland)
Robert Schier
Senior Investment Director
Swisscanto Private Equity
(Switzerland)
Steve Seuntjens
Partner
PHS Fund
(Netherlands)
Pekka Simula
Innovestor Ventures
(Finland)
Marc Sluijs
Managing Partner
DIGITALHEALTH.NETWORK
(Switzerland)
Catello Somma
Associate
TVM Capital
(Germany)
Sriram Srinivasan
Director, EMEA Business Development
Boston Scientific EMEA
(Switzerland)
Prem Tumkosit
Managing Director
MSD Global Health Innovation Fund
(United States)
Arturo Urrios
Principal
Wellington Partners
(Germany)
Ralph BMH van Aken
BD Director EMEA
Medtronic
(Switzerland)
Ann Van Mele
Venture Acceleration Manager at Imec.istart
imec
(Belgium)
David Wehner
Senior Investment Manager
SHS Gesellschaft für Beteiligungsmanagement
(Germany)
Pierre-Jean Wipff
Life Sciences Innovation advisor
Innovaud
(Switzerland)
Francesca Wuttke
Chief Digital Officer
Almirall
(Spain)
Henry Zubaida
Associate
Gilde Healthcare Partners
(Netherlands)
